MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.5659
-0.0341 (-5.68%)
At close: Jun 5, 2026, 4:00 PM EDT
0.5796
+0.0137 (2.42%)
After-hours: Jun 5, 2026, 7:58 PM EDT
MDxHealth Employees
MDxHealth had 364 employees as of December 31, 2025. The number of employees increased by 52 or 16.67% compared to the previous year.
Employees
364
Change (1Y)
52
Growth (1Y)
16.67%
Revenue / Employee
$304,860
Profits / Employee
-$91,146
Market Cap
29.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 364 | 52 | 16.67% | 364 | 0 |
| Dec 31, 2024 | 312 | 12 | 4.00% | 312 | 0 |
| Dec 31, 2023 | 300 | 42 | 16.28% | 300 | 0 |
| Dec 31, 2022 | 258 | 67 | 35.08% | 252 | 6 |
| Dec 31, 2021 | 191 | 14 | 7.91% | 191 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inotiv | 2,046 |
| Burning Rock Biotech | 667 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| bioAffinity Technologies | 57 |
| Advanced Biomed | 31 |
MDXH News
- 4 days ago - MDxHealth Slides: Corporate presentation - Filings
- 22 days ago - MDxHealth price target lowered to $5 from $9 at Lake Street - TheFly
- 22 days ago - MDxHealth price target lowered to $1.50 from $7 at TD Cowen - TheFly
- 22 days ago - MDxHealth downgraded to Market Perform from Outperform at William Blair - TheFly
- 22 days ago - MDxHealth price target lowered to $4 from $7 at BTIG - TheFly
- 22 days ago - MDxHealth to exit the Resolve mdx business - TheFly
- 22 days ago - MDxHealth sees FY26 revenue $110M-$115M, consensus $118.6M - TheFly
- 23 days ago - MDxHealth Earnings Call Transcript: Q1 2026 - Transcripts